arrow
T

Thomas J. Mitchell

University of Cambridge
H指数:71
被引数:4.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Estimating the Sodium Content: A Case Series of Benign and Malignant Renal Tumours Using 23Na-MRI at 3 T

利用3T 23Na-MRI评估良性及恶性肾肿瘤的钠含量:病例系列研究

2026-06-240
OAAI
Improving the diagnosis of renal tumours of young people through integrated molecular analysis

通过整合分子分析改善年轻人肾肿瘤的诊断

2026-04-030
OAAI
Probing intratumoral metabolic compartmentalisation in a patient with fumarate hydratase-deficient renal cancer using clinical hyperpolarised 13C-MRI and mass spectrometry imaging

使用临床高极化¹³C-MRI和质谱成像技术,探查1例富马酸水合酶缺陷型肾癌患者的肿瘤内代谢区室化。

2026-01-130
OAAI
Evaluating the metabolic effects of neoadjuvant treatment in clear cell renal cell carcinoma using hyperpolarized [1-13 C]pyruvate MRI

评估透明细胞肾细胞癌新辅助治疗的代谢效应:采用高极化[1-13 C]丙酮酸MRI

2025-12-010
OAAI
Cambridge kidney One-Stop Mass Investigation Clinic (CkOSMIC): A Nonrandomised Feasibility Study

剑桥肾脏一站式质量检查诊所(CkOSMIC):一项非随机可行性研究

2025-10-140
OAAI
Investigating the mechanisms of neoadjuvant olaparib and cediranib in renal cancer: results of arms 1 to 3 of the WIndow of opportunity in REnal cancer (WIRE) clinical trial

探究新辅助奥拉帕利和西地尼布在肾癌中的作用机制:WIndow of opportunity in REnal cancer (WIRE) 临床试验第1至3组的试验结果

2025-10-010
OAAI
Angiogenic and immune predictors of neoadjuvant axitinib response in renal cell carcinoma with venous tumour thrombus

肾细胞癌静脉肿瘤血栓中轴突生的血管生成和免疫预测因子对新辅助阿昔替尼治疗反应的预测

2025-04-280
OA
Beyond the diagnosis: A town hall event to explore black men's journey with prostate cancer and sexuality
2024-09-210
PRE
Molecular analysis improves the diagnosis of young people with renal tumors
2024-09-050
PRE
Targetable NOTCH1 rearrangements in reninoma
2023-09-251
OAAI